teva pharmaceuticals introduces the first generic glp-1 for weight loss Announces FDA Approval and Launch of Saxenda® (liraglutide injection) – Generic Indicated Subscription:1 month lemon Overview of GLP-1s

teva pharmaceuticals introduces the first generic glp-1 for weight loss Announces FDA Approval and Launch of Saxenda® (liraglutide injection) – Generic Indicated Subscription:1 month lemon Overview of GLP-1s

Overview of GLP-1s

Am J Health-Syst Pharm

lemon

Subscription:1 month

Paul Geevarghese, COO and Co-Founder of 9amHealth, stated in the news release announcing the partnernship, "We're not only lowering the cost of medications, we're also connecting members to real, human care: specialists in obesity and diabetes, clinical pharmacists, and ongoing nutritional support with registered dietitians–all from the comfort of home." Adding to that thought, Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company, said, "At Cost Plus Drugs, our commitment to transparent drug pricing has always been unwavering, and with clinical leaders in obesity like 9amHealth, we are dedicated to providing affordable and accessible healthcare solutions for patients with cardiometabolic conditions." What We Don't Know